Skip to content

Apotheek Leyman Rita

Active
Private limited companyfounded 2012active for 14 yearsHoogstraat 36, 9860 Oosterzele, BelgiumKBO/BCE: BE 0846.995.585
Summary

Apotheek Leyman Rita has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €212,408 and a net result of €19,580. Equity has been growing by about 9.5% per year since 2018. Its solvency ranks better than 80% of 22,774 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-06-2012 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.210.794.702 9860 Oosterzele, since 29-06-2012
Financial year end
31 December
Peppol
Reachable since 12-12-2025

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€62,683
▼ 9.3%
Turnover
≈ €300,000
estimated
Profit
€19,580
▼ 26.4%
Equity
€212,408
▲ 9.2%
Total assets
€308,633
▼ 12.2%
  • 2025 accounts filed 15 days after the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 4.38, cash €91,547Equity €212,408 (68.8% of total assets)Founded in 2012Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 72% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 94+14
equity 68.8% of total assets
Liquidity 82-2
short-term debt 17.9% · cash 29.7%
Profitability 77-1
return on assets 6.3%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.1%▼ -0.1 percentage points vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.38 (2.95 in 2024), above the usual 1.5. Short-term debt is 17.9% and cash 29.7% of total assets. 31.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 80% of them on solvency, 86% on liquidity, 65% on profitability and 59% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 4.38, cash €91,547
NBB · annual accounts
lowers risk · Equity €212,408 (68.8% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 2012
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · 2025 accounts filed 15 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-08-2026, 15 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
15 days late
2024
8 days early
2023
1 day late
2022
3 days late
2021
80 days late
2020
114 days late
2019
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 33 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 85% of companies in retail tradesector median €41,218 · 22,816 companies €212,408 View
  • Positive: 8 profitable years in a rowprofit 2025: €19,580 8 years View

Recent changes

  1. · Gazette deed Change of role: Rita Leyman, from manager to director
  2. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as Apotheek Leyman Rita: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €291,000 and €381,000, founded between 2010 and 2011.

CompanyTotal assetsGross margin
Apotheek Leyman Rita Oosterzele€308,633€62,683
PHARMACIE TAOUS Brussel€305,110€57,236
LEVEUGLE Deinze€297,608€78,564
APOTHEEK BULTEEL Sint-Niklaas€380,923€65,251
DECAPHARMA Knokke-Heist€291,134€65,566
APOTHEEK ROZEMAAI Antwerpen€307,785€58,047
FARMA FLOROSA Heist-op-den-Berg€350,389€58,345
Full comparison

Key facts about Apotheek Leyman Rita

What is the company number of Apotheek Leyman Rita?
The company number of Apotheek Leyman Rita is 0846.995.585. The VAT number is the same number with BE in front: BE 0846.995.585.
Where is Apotheek Leyman Rita based?
The registered office is at Hoogstraat 36, 9860 Oosterzele.Company details
What does Apotheek Leyman Rita do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Leyman Rita?
The legal form of Apotheek Leyman Rita is Private limited company (BV).
When was Apotheek Leyman Rita founded?
Apotheek Leyman Rita was founded on 20-06-2012.
Is Apotheek Leyman Rita still active?
Yes, Apotheek Leyman Rita is an active enterprise in the KBO register.
What is the turnover of Apotheek Leyman Rita?
The turnover in financial year 2025 is ≈ €300,000. This figure is estimated from the gross margin of €62,683 and 44 comparable companies (NACE 477). It probably lies between €160,000 and €420,000.Financials
Is Apotheek Leyman Rita profitable?
In financial year 2025, Apotheek Leyman Rita made a profit of €19,580.
Where can I find the annual accounts of Apotheek Leyman Rita?
Apotheek Leyman Rita filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Leyman Rita due?
Apotheek Leyman Rita must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.